Showing results (1-10 of 373) with videos related to
Sort By:
Pageof 38
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 28, 2024
Familial hypercholesterolemia with special focus on JapanJunji Kobayashi, Takuya Minamizuka, Hayato Tada, et al.Internal Medicine (Tokyo, Japan)|December 3, 2025
Little Evidence of Atherosclerosis in a Middle-Aged Japanese Woman with Familial Hypercholesterolemia Carrying PCSK9 (p.Glu32Lys) and ABCG8 (p.Ile419Asn) Variants Despite Elevated Lipoprotein(a) LevelsKazuto Aono, Junji Kobayashi, Hayato Tada, et al.Clinical Biochemistry|July 12, 2022
Homozygous familial lipoprotein lipase deficiency without obvious coronary artery stenosisTakuya Minamizuka, Junji Kobayashi, Hayato Tada, et al.Internal Medicine (Tokyo, Japan)|July 31, 2024
A Japanese Case of Familial Hypercholesterolemia with a Protein-truncating Variant in LDLR and a PCSK9 Variant without Significant Atherosclerosis but Showing Remarkable Achilles Tendon ThickeningTakuya Minamizuka, Junji Kobayashi, Hayato Tada, et al.Journal of Atherosclerosis and Thrombosis|November 18, 2014
Autosomal recessive hypercholesterolemia: a mild phenotype of familial hypercholesterolemia: insight from the kinetic study using stable isotope and animal studiesHayato Tada, Masa-Aki Kawashiri, Atsushi Nohara, et al.Internal Medicine (Tokyo, Japan)|May 24, 2026
Severe HDL-C Deficiency Caused by Acquired LCAT Deficiency: A Case Report with Lipidomic Profiling and Anti-LCAT Autoantibody DetectionTetta Sato, Junji Kobayashi, Masayuki Kuroda, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|July 20, 2020
Detailed analysis of lipolytic enzymes in a Japanese woman of familial lipoprotein lipase deficiency - Effects of pemafibrate treatmentTakuya Minamizuka, Junji Kobayashi, Hayato Tada, et al.Lipids in Health and Disease|April 4, 2016
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapyHayato Tada, Junji Kobayashi, Masa-Aki Kawashiri, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|March 1, 2011
Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: result from a crossover studyMasa-aki Kawashiri, Junji Kobayashi, Atsushi Nohara, et al.Journal of Atherosclerosis and Thrombosis|August 30, 2016
Lipid Management in a Japanese Community:Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012Hayato Tada, Masa-Aki Kawashiri, Atsushi Nohara, et al.Pageof 38